- Home
- CLDI vs DAIO Comparison
CLDI vs DAIO Comparison
Compare CLDI & DAIO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CLDI
- DAIO
- Stock Information
- Founded
- CLDI 2014
- DAIO 1969
- Country
- CLDI United States
- DAIO United States
- Employees
- CLDI N/A
- DAIO N/A
- Industry
- CLDI Biotechnology: Biological Products (No Diagnostic Substances)
- DAIO Electrical Products
- Sector
- CLDI Health Care
- DAIO Industrials
- Exchange
- CLDI Nasdaq
- DAIO Nasdaq
- Market Cap
- CLDI 20.2M
- DAIO 22.0M
- IPO Year
- CLDI N/A
- DAIO N/A
- Fundamental
- Price
- CLDI $1.76
- DAIO $2.91
- Analyst Decision
- CLDI
- DAIO Strong Buy
- Analyst Count
- CLDI 0
- DAIO 2
- Target Price
- CLDI N/A
- DAIO $4.61
- AVG Volume (30 Days)
- CLDI 1.1M
- DAIO 49.4K
- Earning Date
- CLDI 08-08-2025
- DAIO 07-24-2025
- Dividend Yield
- CLDI N/A
- DAIO N/A
- EPS Growth
- CLDI N/A
- DAIO N/A
- EPS
- CLDI N/A
- DAIO N/A
- Revenue
- CLDI N/A
- DAIO $22,732,000.00
- Revenue This Year
- CLDI N/A
- DAIO $9.52
- Revenue Next Year
- CLDI N/A
- DAIO $5.84
- P/E Ratio
- CLDI N/A
- DAIO N/A
- Revenue Growth
- CLDI N/A
- DAIO N/A
- 52 Week Low
- CLDI $1.61
- DAIO $1.88
- 52 Week High
- CLDI $46.68
- DAIO $3.48
- Technical
- Relative Strength Index (RSI)
- CLDI 29.56
- DAIO 33.92
- Support Level
- CLDI $1.61
- DAIO $3.18
- Resistance Level
- CLDI $6.06
- DAIO $3.37
- Average True Range (ATR)
- CLDI 0.77
- DAIO 0.14
- MACD
- CLDI -0.55
- DAIO -0.04
- Stochastic Oscillator
- CLDI 2.57
- DAIO 37.16
About CLDI Calidi Biotherapeutics Inc.
Calidi Biotherapeutics Inc is a clinical-stage immuno-oncology company with technology designed to arm the immune system to fight cancer. The Company's stem cell-based platforms utilize potent allogeneic stem cells capable of carrying payloads of oncolytic viruses for use in a many oncology indications, including high-grade gliomas and solid tumors. Its products include CLD-101 for Recurrent HGG; CLD-201 for Solid Tumors, and CLD-400 for certain lung cancer and Metastatic Solid Tumors. In addition to its pipeline products, the Company's is also engaged in discovery research of CLD-301 (AAA) for tumor Indications.
About DAIO Data I/O Corporation
Data I/O Corp is a provider of programming, security deployment, security provisioning, and associated Intellectual Property protection and management solutions used in electronics manufacturing with flash memory, microcontrollers, and flash memory-based intelligent devices as well as secure element devices, authentication devices, and secure microcontrollers. It is engaged in focused on the design, manufacturing and sale of programming systems used by designers and manufacturers of electronic products. It has its geographic presence in the United States, Europe, and Asia and others. The company derives the majority of its revenue from Asia and others.